[Carcinogenic properties of serotinin derivatives].
D008735:5-Methoxytryptamine / Q000494:pharmacology; D000818:Animals; D002273:Carcinogens; D002276:Carcinoid Tumor / Q000378:metabolism; D002417:Cattle; D002645:Chickens; D004285:Dogs; D005260:Female; D006168:Guinea Pigs; D000882:Haplorhini; D006897:Hydroxyindoleacetic Acid / Q000031:analogs & derivatives / Q000633:toxicity; D007211:Indoles / Q000633:toxicity; D008550:Melatonin / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D008815:Mice, Inbred Strains; D009369:Neoplasms / Q000378:metabolism; D009374:Neoplasms, Experimental / Q000139:chemically induced / Q000628:therapy; D010870:Pineal Gland / Q000637:transplantation; D011817:Rabbits; D012701:Serotonin / Q000031:analogs & derivatives*; D014364:Tryptophan / Q000378:metabolism
D002273:Carcinogens; D007211:Indoles; D012701:Serotonin; C001736:5-methoxyindoleacetic acid; D008735:5-Methoxytryptamine; D006897:Hydroxyindoleacetic Acid; C030374:indole; D014364:Tryptophan; D008550:Melatonin
Izuchenie kantserogennykh svoĭstv proizvodnykh serotonina.